Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main goal of this study is to gain a thorough understanding, which specific factors drive the unhealthy sequelae of obesity. Therefore, the investigators want to understand:
The hypothesis is, that changes in the molecular regulation of adipose tissue as well as in adipose tissue cellular composition are responsible for the development of a rather metabolic healthy or unhealthy phenotype. Knowledge of these factors will be used to generate new diagnostic concepts for personalized risk prediction and will furthermore serve as the basis to develop novel strategies to target adipose tissue to improve metabolic health.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Rate of conversion | The primary endpoint is the conversion (through study completions, 10 years) from obese but metabolically healthy subjects into obese patients in a pathological metabolic state, through study completion an average of 1 year. | Conversion will be driven by the occurrence of pathological findings caused by obesity (metabolic or cardiovascular pathologies). Through study completion, an average of 1 year. |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of identification of factors | The secondary endpoint is the identification of factors alone or in combination (through study completions, 10 years), that related to this conversion from healthy into pathological obesity. This includes factors like: DEXA scans, White Adipose Tissue, lipid and glucose metabolism, vital signs, physical activity, general health and quality of life status... | Conversion will be driven by the occurrence of pathological findings caused by obesity (metabolic or cardiovascular pathologies), through study completion, an average of 1 year. |
Not provided
Inclusion Criteria:
Inclusion criteria for initially healthy group
Blood pressure < 140/90 mmHg
Normal glucose metabolism
Normal lipid metabolism
o LDL-cholesterol < 5.0 mmol/l
≤ 2 of the following metabolic syndrome criteria combined (excluding waist circumference)
TG > 1.7 mmol/l
HDL-cholesterol > 1.0 mmol/l (male) / > 1.3 mmol/l (female)
Fasting glucose ≥ 5.6 mmol/l
BP ≥ 130/85 mmHg
Exclusion Criteria:
Not provided
Not provided
obese participants
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jörg Goldhahn, Prof. | Contact | 044 633 70 54 | jgoldhahn@ethz.ch | |
| Susanne Müller, MSc | Contact | 044 633 70 54 | susanne.mueller@dtip.ethz.ch |
| Name | Affiliation | Role |
|---|---|---|
| Jörg Goldhahn, Prof. | dTIP / ETH Zürich | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| dTIP / ETH Zürich | Recruiting | Baden | 5404 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D000067329 | Obesity, Metabolically Benign |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |